Serial Number
87113164
Owner
STERIS CORPORATIONAttorney
MARK KUSNERFirst Use Date
Feb 15, 2017
Filing Date
Jul 22, 2016
STERIS LABORATORIES Trademark
Serial Number: 87113164 • Registration: 5341813
Trademark Classes
Class 37 - Building & Construction
Building construction; repair; installation services
Class 39 - Transportation & Storage
Transport; packaging and storage of goods; travel arrangement
Class 40 - Treatment & Processing
Treatment of materials
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
July 22, 2016
Registration Date
November 21, 2017
First Use Anywhere
February 15, 2017
First Use in Commerce
February 15, 2017
Published for Opposition
March 14, 2017
Cancellation Date
June 5, 2024
Goods & Services
contract manufacturing of medical devices and sterilization equipment to the order and specification of others
contract packaging to the order and specification of others
steam sterilization services for others in the field of medical devices and pharmaceutical products
laboratory testing services in the field of medical devices and pharmaceutical products, sterility testing services, namely, sterility assurance, quality control, microbiological testing services, namely, microbiological product bioburden quality control and product antimicrobial properties, laboratory services for analytical testing, services for validating sterilization processes, reusable medical device services quality control, tissue testing services for tissue bioburden, inspection and testing services in the environmental field, cleanroom certification services, namely, testing, analysis and evaluation of cleaning rooms of others to determine conformity with certification standards, disinfectant qualification services, namely, disinfectant quality testing, package integrity testing services, namely, product quality testing, and consultation services for medical device development and product development consultation for the pharmaceutical industries
